NYMX

Nymox Pharmaceutical Corp
NYMX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

46 hedge funds and large institutions have $12.3M invested in Nymox Pharmaceutical Corp in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

93% less call options, than puts

Call options by funds: $113K | Put options by funds: $1.71M

Holders
46
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$113K
Puts
$1.71M
Net Calls
Net Calls Change

Top Buyers

1
+$214K
2
+$194K
3
+$131K
4
BlackRock
BlackRock
New York
+$39.6K
5
Deutsche Bank
Deutsche Bank
Germany
+$30.2K

Top Sellers

1
-$244K
2
-$157K
3
-$90K
4
Citadel Advisors
Citadel Advisors
Florida
-$44.8K
5
AWM
AE Wealth Management
Kansas
-$34K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$50K
27
$43K
28
$42K
29
$39K
30
$31K
31
$30K
32
$25K
33
$24K
34
$22K
35
$22K
36
$19K
37
$18K
38
$15K
39
$14K
40
$14K
41
$11K
42
$7K
43
$6K
44
$5.06K
45
$2K
46
$2K
47
–
48
–
49
–
50
–
1
2